Selected research
Industry Research
Sex Hormones Industry Research Report 2026
Market perspective
The global Sex Hormones market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Sex Hormones is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Sex Hormones is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Sex Hormones is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Sex Hormones include Zizhu Pharma, Sanofi, Novartis, Merck, Pfizer, GSK, Bayer, AstraZeneca and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Sex Hormones market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sex Hormones Market by Company
Zizhu Pharma
Sanofi
Novartis
Merck
Pfizer
GSK
Bayer
AstraZeneca
Cipla
Sex Hormones Segment by Type
Drospirenone
Progesterone
Testosterone
Others
Sex Hormones Segment by Application
Injection
Inhalation
Oral
Topical
Sex Hormones Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sex Hormones market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sex Hormones and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sex Hormones.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Sex Hormones manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Sex Hormones by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Sex Hormones in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Drospirenone
- Progesterone
- Testosterone
- Others
Applications
- Injection
- Inhalation
- Oral
- Topical
Companies covered
- Zizhu Pharma
- Sanofi
- Novartis
- Merck
- Pfizer
- GSK
- Bayer
- AstraZeneca
- Cipla
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Sex Hormones Market Size (2021-2032)
- 2.2.2 Global Sex Hormones Sales (2021-2032)
- 2.2.3 Global Sex Hormones Market Average Price (2021-2032)
- 2.3 Sex Hormones by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Drospirenone
- 2.3.3 Progesterone
- 2.3.4 Testosterone
- 2.3.5 Others
- 2.4 Sex Hormones by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Injection
- 2.4.3 Inhalation
- 2.4.4 Oral
- 2.4.5 Topical
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Sex Hormones Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Sex Hormones Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Sex Hormones Revenue of Manufacturers (2021-2026)
- 3.4 Global Sex Hormones Average Price by Manufacturers (2021-2026)
- 3.5 Global Sex Hormones Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Sex Hormones, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Sex Hormones, Product Type & Application
- 3.8 Global Manufacturers of Sex Hormones, Established Date
- 3.9 Global Sex Hormones Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zizhu Pharma
- 4.1.1 Zizhu Pharma Company Information
- 4.1.2 Zizhu Pharma Business Overview
- 4.1.3 Zizhu Pharma Sex Hormones Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zizhu Pharma Sex Hormones Product Portfolio
- 4.1.5 Zizhu Pharma Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Sex Hormones Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Sex Hormones Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Novartis
- 4.3.1 Novartis Company Information
- 4.3.2 Novartis Business Overview
- 4.3.3 Novartis Sex Hormones Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis Sex Hormones Product Portfolio
- 4.3.5 Novartis Recent Developments
- 4.4 Merck
- 4.4.1 Merck Company Information
- 4.4.2 Merck Business Overview
- 4.4.3 Merck Sex Hormones Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merck Sex Hormones Product Portfolio
- 4.4.5 Merck Recent Developments
- 4.5 Pfizer
- 4.5.1 Pfizer Company Information
- 4.5.2 Pfizer Business Overview
- 4.5.3 Pfizer Sex Hormones Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pfizer Sex Hormones Product Portfolio
- 4.5.5 Pfizer Recent Developments
- 4.6 GSK
- 4.6.1 GSK Company Information
- 4.6.2 GSK Business Overview
- 4.6.3 GSK Sex Hormones Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 GSK Sex Hormones Product Portfolio
- 4.6.5 GSK Recent Developments
- 4.7 Bayer
- 4.7.1 Bayer Company Information
- 4.7.2 Bayer Business Overview
- 4.7.3 Bayer Sex Hormones Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bayer Sex Hormones Product Portfolio
- 4.7.5 Bayer Recent Developments
- 4.8 AstraZeneca
- 4.8.1 AstraZeneca Company Information
- 4.8.2 AstraZeneca Business Overview
- 4.8.3 AstraZeneca Sex Hormones Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 AstraZeneca Sex Hormones Product Portfolio
- 4.8.5 AstraZeneca Recent Developments
- 4.9 Cipla
- 4.9.1 Cipla Company Information
- 4.9.2 Cipla Business Overview
- 4.9.3 Cipla Sex Hormones Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Cipla Sex Hormones Product Portfolio
- 4.9.5 Cipla Recent Developments
5 Global Sex Hormones Market Scenario by Region
- 5.1 Global Sex Hormones Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Sex Hormones Sales by Region: 2021-2032
- 5.2.1 Global Sex Hormones Sales by Region: 2021-2026
- 5.2.2 Global Sex Hormones Sales by Region: 2027-2032
- 5.3 Global Sex Hormones Revenue by Region: 2021-2032
- 5.3.1 Global Sex Hormones Revenue by Region: 2021-2026
- 5.3.2 Global Sex Hormones Revenue by Region: 2027-2032
- 5.4 North America Sex Hormones Market Facts & Figures by Country
- 5.4.1 North America Sex Hormones Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Sex Hormones Sales by Country (2021-2032)
- 5.4.3 North America Sex Hormones Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Sex Hormones Market Facts & Figures by Country
- 5.5.1 Europe Sex Hormones Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Sex Hormones Sales by Country (2021-2032)
- 5.5.3 Europe Sex Hormones Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Sex Hormones Market Facts & Figures by Country
- 5.6.1 Asia Pacific Sex Hormones Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Sex Hormones Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Sex Hormones Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Sex Hormones Market Facts & Figures by Country
- 5.7.1 South America Sex Hormones Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Sex Hormones Sales by Country (2021-2032)
- 5.7.3 South America Sex Hormones Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Sex Hormones Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Sex Hormones Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Sex Hormones Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Sex Hormones Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Sex Hormones Sales by Type (2021-2032)
- 6.1.1 Global Sex Hormones Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Sex Hormones Sales Market Share by Type (2021-2032)
- 6.2 Global Sex Hormones Revenue by Type (2021-2032)
- 6.2.1 Global Sex Hormones Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Sex Hormones Revenue Market Share by Type (2021-2032)
- 6.3 Global Sex Hormones Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Sex Hormones Sales by Application (2021-2032)
- 7.1.1 Global Sex Hormones Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Sex Hormones Sales Market Share by Application (2021-2032)
- 7.2 Global Sex Hormones Revenue by Application (2021-2032)
- 7.2.1 Global Sex Hormones Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Sex Hormones Revenue Market Share by Application (2021-2032)
- 7.3 Global Sex Hormones Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Sex Hormones Value Chain Analysis
- 8.1.1 Sex Hormones Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Sex Hormones Production Mode & Process
- 8.2 Sex Hormones Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Sex Hormones Distributors
- 8.2.3 Sex Hormones Customers
9 Global Sex Hormones Analyzing Market Dynamics
- 9.1 Sex Hormones Industry Trends
- 9.2 Sex Hormones Industry Drivers
- 9.3 Sex Hormones Industry Opportunities and Challenges
- 9.4 Sex Hormones Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst